NCT02925000View on ClinicalTrials.gov

Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

October 6, 2020

Study Completion Date

October 6, 2020

Conditions
Cancer
Interventions
DRUG

TLC178

TLC178

Trial Locations (3)

112

Taipei Veterans General Hospital, Taipei

10461

Montefiore Medical Center, The Bronx

48201

Karmanos Cancer Center, Detroit

Sponsors
All Listed Sponsors
lead

Taiwan Liposome Company

INDUSTRY